Metabolomic and Physiological Effects of a Cardiorenal Protective Diet Intervention in African American Adults with Chronic Kidney Disease DOI Creative Commons
Meera Patel,

Chiamaka Emerenini,

Xuan Wang

et al.

Metabolites, Journal Year: 2024, Volume and Issue: 14(6), P. 300 - 300

Published: May 25, 2024

Chronic kidney disease (CKD) impacts 14% of adults in the United States, and African American (AA) individuals are disproportionately affected, with more than 3 times higher risk failure as compared to White individuals. This study evaluated effects base-producing fruit vegetables (FVs) on cardiorenal outcomes AA persons CKD hypertension (HTN) a low socioeconomic area. The “Cardiorenal Protective Diet” prospective randomized trial 6-week, community-based FV intervention waitlist control (WL) 91 (age = 58.3 ± 10.1 years, 66% female, 48% income ≤ USD 25K). Biometric metabolomic variables were collected at baseline 6 weeks post-intervention. change health for both groups was statistically insignificant (p > 0.05), though small reductions albumin creatinine ratio, body mass index, total cholesterol, systolic blood pressure observed group. Metabolomic profiling identified key markers < including C3, C5, 1-Met-His, kynurenine, PC ae 38:5, choline, indicating function decline WL Overall, delivering directed protective diet improved HTN. Additionally, may serve prognostic technique early identification biomarkers indicators worsening increased CVD risk.

Language: Английский

Plasma and Urine Metabolites Associated With Non-diabetic Chronic Kidney Disease: The HELIUS Study DOI Creative Commons
Charlotte M. Mosterd, Barbara J. H. Verhaar, Bert‐Jan H. van den Born

et al.

Kidney Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 101009 - 101009

Published: April 1, 2025

Language: Английский

Citations

0

Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI DOI Creative Commons
Sami Alobaidi

Diagnostics, Journal Year: 2025, Volume and Issue: 15(10), P. 1225 - 1225

Published: May 13, 2025

Chronic kidney disease (CKD) remains a significant global health burden, often diagnosed at advanced stages due to the limitations of traditional biomarkers such as serum creatinine and estimated glomerular filtration rate (eGFR). This review aims critically evaluate recent advancements in novel biomarkers, multi-omics technologies, artificial intelligence (AI)-driven diagnostic strategies, specifically addressing existing gaps early CKD detection personalized patient management. We explore key diagnostics, focusing on emerging biomarkers—including neutrophil gelatinase-associated lipocalin (NGAL), injury molecule-1 (KIM-1), soluble urokinase plasminogen activator receptor (suPAR), cystatin C—and their clinical applications. Additionally, approaches integrating genomics, proteomics, metabolomics, transcriptomics are reshaping classification prognosis. Artificial predictive models further enhance accuracy, enabling real-time risk assessment treatment optimization. Despite these innovations, challenges remain biomarker standardization, large-scale validation, integration into practice. Future research should focus refining multi-biomarker panels, improving assay facilitating adoption precision-driven diagnostics. By leveraging advancements, diagnostics can transition toward earlier intervention, individualized therapy, improved outcomes.

Language: Английский

Citations

0

Development of a time-resolved immunochromatographic test strip for rapid and quantitative determination of retinol-binding protein 4 in urine DOI

Wenjie Guo,

Zhiyong Yu,

Tianxu Li

et al.

Microchimica Acta, Journal Year: 2024, Volume and Issue: 191(6)

Published: May 8, 2024

Language: Английский

Citations

3

Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation DOI Creative Commons

Aya Awwad,

Eugene P. Rhee, Morgan E. Grams

et al.

BMC Nephrology, Journal Year: 2024, Volume and Issue: 25(1)

Published: May 30, 2024

Protein carbamylation, a post-translational protein modification primarily driven by urea, independently associates with adverse clinical outcomes in patients CKD. Biomarkers used to quantify carbamylation burden have mainly included carbamylated albumin (C-Alb) and homocitrulline (HCit, lysine). In this study, we aimed compare the prognostic utility of these two markers order facilitate comparisons existing studies employing either marker alone, inform future studies.

Language: Английский

Citations

3

The potential mediating role of the gut microbiome and metabolites in the association between PFAS and kidney function in young adults: A proof-of-concept study DOI

Hailey Hampson,

Shiwen Li, Douglas I. Walker

et al.

The Science of The Total Environment, Journal Year: 2024, Volume and Issue: unknown, P. 176519 - 176519

Published: Oct. 1, 2024

Language: Английский

Citations

3

Relationship of different sourced protein intake, quantity of plasma amino acid with chronic kidney disease DOI
Chun Zhou, Sisi Yang, Ziliang Ye

et al.

Journal of Nutrition, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

0

Integrated NMR and MS Analysis of the Plasma Metabolome Reveals Major Changes in One-Carbon, Lipid, and Amino Acid Metabolism in Severe and Fatal Cases of COVID-19 DOI Creative Commons
Marcos C. Gama-Almeida, Gabriela D.A. Pinto, Lívia Teixeira

et al.

Metabolites, Journal Year: 2023, Volume and Issue: 13(7), P. 879 - 879

Published: July 24, 2023

Brazil has the second-highest COVID-19 death rate worldwide, and Rio de Janeiro is among states with highest in country. Although vaccine coverage been achieved, it anticipated that will transition into an endemic disease. It concerning molecular mechanisms underlying clinical evolution from mild to severe disease, as well leading long COVID-19, are not yet fully understood. NMR MS-based metabolomics were used identify metabolites associated pathophysiology disease outcome. Severe cases (n = 35) enrolled two reference centers within 72 h of ICU admission, alongside 12 non-infected control subjects. patients grouped survivors 18) non-survivors 17). Choline-related metabolites, serine, glycine, betaine, reduced indicating dysregulation methyl donors. Non-survivors had higher levels creatine/creatinine, 4-hydroxyproline, gluconic acid, N-acetylserine, liver kidney dysfunction. Several changes greater women; thus, patients' sex should be considered pandemic surveillance achieve better stratification improve outcomes. These metabolic alterations may useful monitor organ (dys) function understand acute possibly post-acute syndromes.

Language: Английский

Citations

7

Metabolomics in atrial fibrillation - A review and meta-analysis of blood, tissue and animal models DOI Creative Commons

Leonoor F.J. Wijdeveld,

Amelie C. T. Collinet, Fabries G. Huiskes

et al.

Journal of Molecular and Cellular Cardiology, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

2

Plasma Metabolomics of Dietary Intake of Protein-Rich Foods and Kidney Disease Progression in Children DOI Creative Commons

Xuyuehe Ren,

Jingsha Chen,

Alison G. Abraham

et al.

Journal of Renal Nutrition, Journal Year: 2023, Volume and Issue: 34(2), P. 95 - 104

Published: Nov. 8, 2023

Language: Английский

Citations

5

Aptamer-Based Proteomics in CKD DOI Open Access
Taesoo Kim, Eugene P. Rhee

American Journal of Kidney Diseases, Journal Year: 2024, Volume and Issue: 83(6), P. 825 - 828

Published: Jan. 27, 2024

Language: Английский

Citations

1